Methyl 4-(N-piperidin-4-ylsulfamoyl)benzoate hydrochloride, 95.0%, 1g

N-Boc-Cyclopropylamine, 98.0%, 10g

1,4-DIMETHYLPYRIDINIUM IODIDE, 95%, 5g

Gallic acid, min. 98%, pa, ACS, anhydrous, 250 g, glass packaging

4-butoxy-3-chloro-5-methoxybenzaldehyde, 95.0%, 100mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazolo[5,4-b]pyridine, 97%, 1g

4-BROMO-6-FLUORO-1H-INDAZOLE, 95%, 10g

5-Amino-1-methylpyridin-2(1H)-one hydrochloride, 95.0%, 10g

Benzamide, 2-chloro-N-[[2'-[(cyanoamino)sulfonyl][1,1'-biphenyl]-4-yl]methyl]-N-[(4-methylphenyl)methyl]-, 98%, 10mg

boc-n-me-tyr-oh.dcha, 95.0%, 250mg

3-Amino-4-chlorobenzoic Acid>98.0%(HPLC)(T)500g

4-(Methoxycarbonyl)-3-(trifluoromethyl)benzoic acid, 98%, 5g

DIMETHYL 2-(4-CHLOROPHENYL)SUCCINATE, 95.0%, 250mg